MarketPulse

capital runway

2 articles
The Motley FoolThe Motley Fool··Jonathan Ponciano

BVF's $52M Stake in Disc Medicine Signals Confidence Despite Regulatory Hurdles

BVF Partners invests $52M in Disc Medicine despite FDA setbacks, betting on Phase 3 trial data and strong cash reserves through 2029.
KYMRRVMDRVMDWIRONFDA approvalclinical trial
The Motley FoolThe Motley Fool··Courtney Carlsen

QuantumScape Advances Solid-State Battery Development Despite Valuation Uncertainty

QuantumScape hits solid-state battery milestones with 2029 production target, but faces years before revenue generation and substantial execution risks remain.
GLWQSVWAGYelectric vehiclescapital runway